These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2596440)

  • 1. Naloxone challenge as a biological predictor of treatment outcome in opiate addicts.
    Jacobsen LK; Kosten TR
    Am J Drug Alcohol Abuse; 1989; 15(4):355-66. PubMed ID: 2596440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of precipitated opiate withdrawal predicts drug dependence by DSM-III-R criteria.
    Kosten TA; Jacobsen LK; Kosten TR
    Am J Drug Alcohol Abuse; 1989; 15(3):237-50. PubMed ID: 2763981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial methadone dose in treating opiate addiction.
    Wang RI; Kochar C; Hasegawa AT; Roh BL
    Int J Addict; 1982 Feb; 17(2):357-63. PubMed ID: 7076369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment.
    Loimer N; Schmid RW; Presslich O; Lenz K
    J Psychiatr Res; 1989; 23(1):81-6. PubMed ID: 2547057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differences in depression severity and frequency of relapses in opiate addicts treated with methadone or opiate blocker after detoxification].
    Jovanović T; Lazarević D; Nikolić G
    Vojnosanit Pregl; 2012 Apr; 69(4):326-32. PubMed ID: 22624424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome.
    Rounsaville BJ; Weissman MM; Crits-Christoph K; Wilber C; Kleber H
    Arch Gen Psychiatry; 1982 Feb; 39(2):151-6. PubMed ID: 7065829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient comparison of buprenorphine and methadone maintenance. I. Effects on opiate use and self-reported adverse effects and withdrawal symptomatology.
    Johnson RE; Fudala PJ; Jaffe JH
    NIDA Res Monogr; 1990; 105():585-6. PubMed ID: 1876130
    [No Abstract]   [Full Text] [Related]  

  • 10. The Beck Depression Inventory in patients undergoing opiate agonist maintenance treatment.
    Hesse M
    Br J Clin Psychol; 2006 Sep; 45(Pt 3):417-25. PubMed ID: 17147106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to methadone maintenance and counseling in antisocial patients with and without major depression.
    Alterman AI; Rutherford MJ; Cacciola JS; McKay JR; Woody GE
    J Nerv Ment Dis; 1996 Nov; 184(11):695-702. PubMed ID: 8955683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
    Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipramine as treatment for depression in addicts.
    Kleber HD; Weissman MM; Rounsaville BJ; Wilber CH; Prusoff BA; Riordan CE
    Arch Gen Psychiatry; 1983 Jun; 40(6):649-53. PubMed ID: 6342564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dysphoria of heroin addiction.
    Handelsman L; Aronson MJ; Ness R; Cochrane KJ; Kanof PD
    Am J Drug Alcohol Abuse; 1992; 18(3):275-87. PubMed ID: 1329491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of psychiatric diagnosis in treated opiate addicts.
    Rounsaville BJ; Weissman MM; Kleber H; Wilber C
    Arch Gen Psychiatry; 1982 Feb; 39(2):161-8. PubMed ID: 7065830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use predicts treatment outcome, not opiate dependence or withdrawal.
    Kosten TA; Bianchi MS; Kosten TR
    NIDA Res Monogr; 1989; 95():459-60. PubMed ID: 2641030
    [No Abstract]   [Full Text] [Related]  

  • 17. Opiate withdrawal.
    Farrell M
    Addiction; 1994 Nov; 89(11):1471-5. PubMed ID: 7841858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two new rating scales for opiate withdrawal.
    Handelsman L; Cochrane KJ; Aronson MJ; Ness R; Rubinstein KJ; Kanof PD
    Am J Drug Alcohol Abuse; 1987; 13(3):293-308. PubMed ID: 3687892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol use and psychopathology in opioid addicts on methadone maintenance.
    Roszell DK; Calsyn DA; Chaney EF
    Am J Drug Alcohol Abuse; 1986; 12(3):269-78. PubMed ID: 3503569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone applied to conjunctiva as a test for physical opiate dependence.
    Creighton FJ; Ghodse AH
    Lancet; 1989 Apr; 1(8641):748-50. PubMed ID: 2564564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.